Yesterday's edition of Bioshares rates LBT a BUY (Speculative class A).
They say machines will sell for $300,000 and pay for themselves within 2 years time. Also that BB believes we are at least 2 yrs ahead of competition and that our market is 12,000 medium-sized labs.
Regarding the news that Copan are working on similar technology. I don't think this is all bad news as it means this technology is definitely the way of the future. Also it remains to be seen how their technology compares (our patents might give us an advantage). It is the very large labs that currently use their automation technology. Admittedly, they have the advantage of greater resources to draw on, as they make money from selling swabs.
- Forums
- ASX - By Stock
- LBT
- Ann: LBT Innovations Conference Call with CEO & MD Brent Barnes
Ann: LBT Innovations Conference Call with CEO & MD Brent Barnes, page-25
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.98M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $17.02K | 1.064M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1913726 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 606743 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1913726 | 0.015 |
6 | 1381428 | 0.014 |
1 | 600000 | 0.013 |
2 | 6718666 | 0.012 |
2 | 78500 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 606743 | 2 |
0.017 | 727416 | 2 |
0.018 | 1604121 | 9 |
0.019 | 1316951 | 8 |
0.020 | 1685548 | 5 |
Last trade - 11.38am 21/10/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online